Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Rossner

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Acta Neuropathologica|February 11, 2015
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's diseaseMaike Hartlage-Rübsamen, Alexander Waniek, Juliane Meissner, et al.
Obesity (Silver Spring, Md.)|April 19, 2013
Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expressionAlbrecht Hoffmeister, Jan Tuennemann, Ines Sommerer, et al.
The Journal of Biological Chemistry|February 19, 2011
Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug developmentStephan Schilling, Stephanie Kohlmann, Christoph Bäuscher, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgammaMagdalena Sastre, Ilse Dewachter, Steffen Rossner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Bepridil and amiodarone simultaneously target the Alzheimer's disease beta- and gamma-secretase via distinct mechanismsStefan Mitterreiter, Richard M Page, Frits Kamp, et al.
Journal of Neurochemistry|October 8, 2015
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and PeripheryLeona Wagner, Raik Wolf, Ulrike Zeitschel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2016
Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque depositionDisha Shah, Jelle Praet, Amira Latif Hernandez, et al.
Nature Medicine|October 7, 2008
Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathologyStephan Schilling, Ulrike Zeitschel, Torsten Hoffmann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 9, 2011
Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formationAnca Alexandru, Wolfgang Jagla, Sigrid Graubner, et al.
The EMBO Journal|January 3, 2023
Jacob-induced transcriptional inactivation of CREB promotes Aβ-induced synapse loss in Alzheimer's diseaseKatarzyna M Grochowska, Guilherme M Gomes, Rajeev Raman, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Acta Neuropathologica|February 11, 2015
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's diseaseMaike Hartlage-Rübsamen, Alexander Waniek, Juliane Meissner, et al.
Obesity (Silver Spring, Md.)|April 19, 2013
Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expressionAlbrecht Hoffmeister, Jan Tuennemann, Ines Sommerer, et al.
The Journal of Biological Chemistry|February 19, 2011
Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug developmentStephan Schilling, Stephanie Kohlmann, Christoph Bäuscher, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgammaMagdalena Sastre, Ilse Dewachter, Steffen Rossner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Bepridil and amiodarone simultaneously target the Alzheimer's disease beta- and gamma-secretase via distinct mechanismsStefan Mitterreiter, Richard M Page, Frits Kamp, et al.
Journal of Neurochemistry|October 8, 2015
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and PeripheryLeona Wagner, Raik Wolf, Ulrike Zeitschel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2016
Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque depositionDisha Shah, Jelle Praet, Amira Latif Hernandez, et al.
Nature Medicine|October 7, 2008
Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathologyStephan Schilling, Ulrike Zeitschel, Torsten Hoffmann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 9, 2011
Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formationAnca Alexandru, Wolfgang Jagla, Sigrid Graubner, et al.
The EMBO Journal|January 3, 2023
Jacob-induced transcriptional inactivation of CREB promotes Aβ-induced synapse loss in Alzheimer's diseaseKatarzyna M Grochowska, Guilherme M Gomes, Rajeev Raman, et al.
Pageof 4